onset of action semaglutide Two-year effects in adults with overweight or obesity: the STEP 5 trial The weight-loss-independent hepatoprotective benefits of

While using a medication from each class in combination does not pose a safety concern for patients, there is no evidence supporting additive efficacy with this combination

Abstract Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been widely used for type 2 diabetes (T2D) and weight management

Our mission is to provide transparency and quality, ensuring you have access to the medication that fits your clinical needs and your budget

If additional glycemic control is needed after at least 4 weeks on the 1 mg dose: Increase to 2 mg subcutaneously once a week

New Address:

Separate-vial workflow Staggered Co-Titration - Two Vials, Two Schedules Run tirzepatide alone for 8 weeks first